Aleve Launches Project DIY Campaign Featuring Dave and Jenny Marrs to Celebrate Passion Projects and Long-Lasting Pain Relief Aleve®, one of the leading over-the-counter pain relief brands, has unveiled a new consumer marketing initiative called Project DIY, a campaign designed…
Biocytogen’s Boston Research Facility Earns AAALAC International Full Accreditation, Reinforcing Commitment to Scientific Excellence and Animal Welfare Biocytogen has announced a significant achievement for its U.S. research operations, revealing that its Boston research facility has been awarded Full Accreditation by…
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Development of Innovative PTSD Treatment Otsuka America, Inc., a subsidiary of the global healthcare company Otsuka Pharmaceutical Co., Ltd., has completed its acquisition of Transcend Therapeutics, Inc., a biotechnology company focused on…
Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Outbreak Response in Democratic Republic of the Congo and Uganda Cepheid, a molecular diagnostics company and part of Danaher Corporation, has announced the donation of an initial shipment of its Xpert® Hemorrhagic…
Paragon Biosciences Completes Sale of Emalex Biosciences to Teva, Marking Another Milestone in CNS Drug Innovation Paragon Biosciences has announced the successful completion of the sale of Emalex Biosciences to Teva Pharmaceutical Industries, a transaction that highlights Paragon’s strategy of…
LivaNova Strengthens Board Leadership with Appointment of Jette Nygaard-Andersen LivaNova PLC, a global medical technology company focused on developing innovative therapies for patients with neurological and cardiovascular conditions, has announced the election of Jette Nygaard-Andersen to its Board of Directors…
Merck Animal Health to Acquire TARGAN, Expanding Poultry Technology and Biodevice Innovation Capabilities Merck Animal Health, known as MSD Animal Health outside the United States and Canada and operating as a division of Merck & Co., Inc., has announced the…
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors and Audit Committee Leadership Role Vir Biotechnology has announced the appointment of Timothy Coughlin to its Board of Directors, effective June 9, 2026. In addition to joining the board, Coughlin will…
Blue Matter Expands Healthcare Policy Support Capabilities for Life Sciences, Led by Partner Milena Sullivan Blue Matter has announced the launch of an expanded healthcare policy capability designed specifically to support biopharmaceutical clients navigating an increasingly complex regulatory and reimbursement…
Alesis LLC Expands Apnea Network with Three New Joint Ventures Across Chicago, Upper Michigan, and South Florida Within a Week Alesis LLC has announced a rapid expansion of its Alesis Apnea Network, adding three new joint venture clinic locations within…
Corsair Pharma to Present Three Phase 1 Clinical Data Readouts for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference Corsair Pharma, Inc., a privately held biopharmaceutical company focused on innovative drug delivery systems for cardiopulmonary diseases, has announced…
Vizgen® to Advance Cell Atlas Research with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting Vizgen, Inc., a spatial multiomics company and developer of the MERSCOPE Ultra™ platform, has announced a major expansion of its spatial…